Kamala Harris mistakenly credited a nonexistent federal agency with approving mifepristone in 2000, the first drug used in a two-drug medication abortion regimen.
On the mifepristone issue, it’s politicians finding a court, targeting a specific court that they thought would be helpful to them, to take a medication off the market, which was approved 20 years ago by the Federal Drug Administration,” Harris said.
Harris claimed that if the FDA’s approval of mifepristone can be challenged, the same thing “could happen to any one of those drugs in your medicine cabinet.”in November 2022 against the FDA on behalf of four national medical associations and several doctors, alleging that the agency “chose politics over science and approved chemical abortion drugs for use in the United States.
In April, Judge Matthew Kacsmaryk of the U.S. District Court for the Northern District of Texas handed down a 67-page decision that the FDA’s decisions were illegal under federal law and aRELATED — Planned Parenthood CEO: Ignoring Court Ruling on Abortion Pill Dangerously Sacrifices Crucial Institutions for Power
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Kamala Harris says wrong name for FDA in interview about mifepristoneHarris mistakenly said the Federal Drug Administration approved the abortion pill mifepristone more than two decades ago — but such an agency doesn’t exist.
Read more »
Ellie Goulding Celebrated Earth Day With Vice Pres. Kamala HarrisThe singer invited fans to join her for a beach clean-up in Santa Monica last month.
Read more »
Joe Biden Announces 2024 Reelection Bid With VP Kamala HarrisPresident Joe Biden is ready to do it all again and run for reelection -- with VP Kamala Harris right at his side.
Read more »
Joe Biden embraces Kamala Harris for 2024 runDespite some skepticism surrounding Harris' job as vice president, Biden has kept her on the 2024 ticket. Experts say he'll need her to win reelection.
Read more »